Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/80646
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Teede, H. | - |
dc.contributor.author | Ng, S. | - |
dc.contributor.author | Hedger, M. | - |
dc.contributor.author | Moran, L. | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Metabolism: clinical and experimental, 2013; 62(10):1394-1400 | - |
dc.identifier.issn | 0026-0495 | - |
dc.identifier.issn | 1532-8600 | - |
dc.identifier.uri | http://hdl.handle.net/2440/80646 | - |
dc.description.abstract | <h4>Objective</h4>Polycystic ovary syndrome (PCOS) is common and has reproductive and metabolic manifestations. Activin A and follistatin levels remain controversial and activin B levels are unstudied in PCOS. The aim of this study was to evaluate activin A, activin B and follistatin levels and to examine their associations with metabolic status in overweight and obese women with and without PCOS.<h4>Materials and methods</h4>Cross-sectional study assessing overweight and obese, premenopausal women with PCOS (n=51, n=26 National Institutes of Health (NIH) and n=25 non-NIH) and without PCOS (n=25 controls). Outcomes included activin A, activin B, follistatin and activin A/follistatin ratio and the association of the activins and follistatin with metabolic variables.<h4>Results</h4>Activin A, activin B and activin A/follistatin ratio were not significantly different and follistatin was elevated for PCOS versus controls (P=0.01) independent of age or BMI. Follistatin levels were significantly different across the PCOS phenotypes (p=0.05), however this was a non-significant trend (after correction for age and BMI) for women with NIH PCOS or non-NIH PCOS to have elevated levels in comparison to controls. Activin A was most strongly predicted by low density lipoprotein/high density lipoprotein (r(2)=0.192, p<0.001), follistatin by triglycerides and highly sensitive C-reactive protein (r(2)=0.340, p<0.001) and the activin A/follistatin ratio by insulin area under the curve and mean arterial pressure (r(2)=0.289, p<0.001).<h4>Conclusions</h4>Follistatin is elevated and activins A and B are not different between PCOS and controls. Follistatin and activin A are related to metabolic parameters in women with and without PCOS. Follistatin may potentially act as a marker of or be involved in the pathophysiology of both reproductive and metabolic features of PCOS. | - |
dc.description.statementofresponsibility | Helena Teede, Sze Ng, Mark Hedger, Lisa Moran | - |
dc.language.iso | en | - |
dc.publisher | W B Saunders Co | - |
dc.rights | Copyright © 2013 Elsevier Inc. All rights reserved. | - |
dc.source.uri | http://dx.doi.org/10.1016/j.metabol.2013.05.003 | - |
dc.subject | Polycystic ovary syndrome | - |
dc.subject | Activin | - |
dc.subject | Follistatin | - |
dc.title | Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/j.metabol.2013.05.003 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Teede, H. [0000-0001-7609-577X] | - |
dc.identifier.orcid | Moran, L. [0000-0001-5772-6484] | - |
Appears in Collections: | Aurora harvest Obstetrics and Gynaecology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.